Welcome to our dedicated page for AdvanSix SEC filings (Ticker: ASIX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AdvanSix Inc. filings document an integrated chemistry issuer with common stock traded on the NYSE under ASIX. Its 8-K reports furnish operating results for Nylon Solutions, Plant Nutrients and Chemical Intermediates, cash dividends on common stock, executive and director appointments, committee assignments, and amendments to its senior secured revolving credit facility.
Proxy materials disclose board composition, independence, committee structure, executive compensation, equity awards and shareholder voting matters. The filing record also covers capital structure, financial obligations and governance practices tied to AdvanSix's vertically integrated manufacturing assets, raw-material exposure, plant operations and end markets for nylon, fertilizers and chemical intermediates.
AdvanSix Inc. senior vice president and general counsel Achilles B. Kintiroglou reported a tax-related share disposition. On February 28, 2026, 8,008 shares of common stock were withheld at $17.47 per share to cover tax obligations tied to vested restricted stock units. After this withholding, he directly owned 50,363 shares of AdvanSix common stock.
AdvanSix Inc. senior vice president and chief human resources officer Kelly Slieter reported a tax-related share disposition. On February 28, 2026, 5,424 shares of common stock were withheld at $17.47 per share to satisfy tax obligations from vested restricted stock units.
After this withholding, Slieter directly owned 65,029 shares of AdvanSix common stock.
AdvanSix Inc. Chief Executive Officer Erin N. Kane reported a tax-related share disposition. On February 28, 2026, 33,642 shares of common stock were withheld at $17.47 per share to satisfy tax withholding obligations on Restricted Stock Units that vested that day. After this withholding, Kane directly owned 623,103 common shares.
AdvanSix Inc. reported that VP and Controller Rachael E. Ryan acquired 5,621 shares of common stock on February 26, 2026 through a restricted stock unit grant. These units were issued under the company’s 2016 Stock Incentive Plan and are scheduled to vest in three equal annual installments over three years.
AdvanSix Inc. reported that SVP and General Counsel Achilles B. Kintiroglou acquired 28,106 shares of common stock through a grant of restricted stock units at a reference price of $17.79 per share. These units were granted under the 2016 Stock Incentive Plan and are scheduled to vest in three equal annual installments on the first three anniversaries of the grant date. Following this award, he directly holds 58,371 common shares.
AdvanSix Inc. reported that SVP and Chief HR Officer Kelly Slieter acquired 22,485 shares of common stock through a grant of restricted stock units valued at $17.79 per share. These units are scheduled to vest in three equal annual installments beginning on the first anniversary of the grant date. Following this award, Slieter directly owns 70,453 shares of AdvanSix common stock.
AdvanSix Inc. reported that its VP and Interim CFO, Christopher Gramm, acquired 21,079 shares of common stock on February 26, 2026 through an equity award. The award was granted at $17.79 per share under the company’s 2016 Stock Incentive Plan and is structured as restricted stock units.
The restricted stock units are scheduled to vest in three equal annual installments on the first three anniversaries of the grant date, aligning the executive’s compensation with long-term company performance. After this grant, Gramm directly beneficially owns 75,649 shares of AdvanSix common stock.
AdvanSix Inc. reported that Chief Executive Officer Erin N. Kane acquired 111,298 shares of common stock on February 26, 2026 through a grant of restricted stock units under the company’s 2016 Stock Incentive Plan at a reference price of $17.79 per share.
The restricted stock units are scheduled to vest in three equal annual installments on the first three anniversaries of the grant date. Following this award, Kane directly holds 656,745 shares of AdvanSix common stock.
AdvanSix Inc. reports 2025 results showing a broadly stable business built on an integrated U.S. chemical manufacturing footprint. The company generated $1,522 million in sales and $49 million in net income, with operations centered on nylon solutions, plant nutrients and chemical intermediates.
Plant nutrients were the largest contributor at 37% of sales, followed by chemical intermediates at 25%, caprolactam at 18% and nylon at 20%. Management highlights a low-cost position in caprolactam and ammonium sulfate, diversified end markets, and a disciplined capital allocation framework, while noting cyclical demand, raw material price volatility, operational disruptions and cybersecurity as key risks.
AdvanSix Inc. reported full-year 2025 sales of $1.52 billion, essentially flat with 2024, while net income grew to $49.3 million and diluted earnings per share rose to $1.80. Adjusted EBITDA increased to $156.8 million, giving a 10.3% margin.
Fourth-quarter 2025 sales were $360 million, up about 9% year over year, with higher volumes but a small net loss of $2.8 million, or $(0.10) per share, and adjusted EPS of $0.03. Free cash flow improved to $36.1 million in the quarter and $6.4 million for the year as capital spending declined.
The board declared a quarterly cash dividend of $0.16 per share, payable March 23, 2026 to shareholders of record on March 9, 2026. Looking to 2026, the company plans capital expenditures of $75–$95 million, expects plant turnaround impacts of $20–$25 million, and is targeting about $30 million of annual non-manpower fixed cost savings, supported by ongoing benefits from 45Q carbon capture tax credits and 100% bonus depreciation.